Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? (Q56507904)

scholarly article by Nanda Gruben et al published November 2014 in BBA: Molecular Basis of Disease

Language	Label	Description	Also known as
English	Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?	scholarly article by Nanda Gruben et al published November 2014 in BBA: Molecular Basis of Disease

Statements

instance of

scholarly article

0 references

title

Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? (English)

0 references

1 reference

0 references

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

Ronit Shiri-Sverdlov

2

0 references

author name string

Nanda Gruben

series ordinal

1

0 references

Debby P.Y. Koonen

series ordinal

3

0 references

Marten H. Hofker

series ordinal

4

0 references

publication date

November 2014

0 references

published in

BBA: Molecular Basis of Disease

0 references

volume

1842

0 references

page(s)

2329-2343

0 references

issue

11

0 references

cites work

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

2 references

28 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1002/HEP.22363

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Deletion of tumor necrosis factor-alpha receptor type 1 exacerbates insulin resistance and hepatic steatosis in aromatase knockout mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Ceramides and glucosylceramides are independent antagonists of insulin signaling

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Selective insulin and leptin resistance in metabolic disorders

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The origins and drivers of insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Selective versus total insulin resistance: a pathogenic paradox

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Receptors for tumor necrosis factor-alpha play a protective role against obesity and alter adipose tissue macrophage status

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Role of ceramides in nonalcoholic fatty liver disease

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease

2 references

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

28 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1371/JOURNAL.PONE.0030668

Regulation of TNF-induced NF-κB activation by different cytoplasmic ubiquitination events

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Hepatocytes: critical for glucose homeostasis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The burden of liver disease in Europe: a review of available epidemiological data

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

NOX4 pathway as a source of selective insulin resistance and responsiveness

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A ceramide-centric view of insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Lipid-induced insulin resistance: unravelling the mechanism

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Animal models of nonalcoholic fatty liver disease

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Critical role of Kupffer cells in the management of diet-induced diabetes and obesity.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Prevention of steatosis by hepatic JNK1

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The metabolically benign and malignant fatty liver

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Human fatty liver disease: old questions and new insights

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Modulation of the JNK pathway in liver affects insulin resistance status

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Increased macrophage migration into adipose tissue in obese mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Hepatic glycosphingolipid deficiency and liver function in mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A lipidomic analysis of nonalcoholic fatty liver disease.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

IKK-beta links inflammation to obesity-induced insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model

2 references

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

28 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1002/HEP.26046

The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Obesity and diabetes in TNF-alpha receptor- deficient mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Phorbol esters stimulate the phosphorylation of receptors for insulin and somatomedin C

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1β-induced chronic inflammation

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Animal models of non-alcoholic steatohepatitis: of mice and man.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Kupffer cell activation is a causal factor for hepatic insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice.

2 references

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

28 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.ATHEROSCLEROSIS.2013.11.074

Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor gamma coactivator 1 beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese mice.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Mechanisms for insulin resistance: common threads and missing links

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

NF-kappaB: a key role in inflammatory diseases

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The membrane lipid phosphatidylcholine is an unexpected source of triacylglycerol in the liver

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Identifiers

DOI

10.1016/J.BBADIS.2014.08.004

0 references

PubMed ID

25128743

0 references

ResearchGate publication ID

264830536

0 references

Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? (Q56507904)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? (Q56507904)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search